Announcements Trials

Browse Landscape

Phase

Status

Completed 477 Recruiting 113 Terminated 102 Active not recruiting 97 Unknown 84 Withdrawn 36 Not yet recruiting 20 Suspended 7 No longer available 2 Enrolling by invitation 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Cisplatin 9 Specimen Handling 7 Educational Status 7 Standard of Care 6 Interviews as Topic 6 Drug Therapy 6 Carboplatin 6 Blood Specimen Collection 6 Radiotherapy 5 Nivolumab 5 Chemoradiotherapy 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Paclitaxel 4 Oxaliplatin 4 Observation 4 Lenalidomide 4 Fluorouracil 4 Fluorodeoxyglucose F18 4 Dexamethasone 4 pembrolizumab 3 lenvatinib 3 camrelizumab 3 Practice Guidelines as Topic 3 Patient Navigation 3 Methods 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Gemcitabine 3 Exercise 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Prednisone × Clear all

NCT07258680 2025-12-02

BrEto-TCL

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡